VEGF-C Antibody (193208) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # FAB752F

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 193208
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human VEGF-C
Thr103-Arg227 (Cys156Ser)
Accession # Q6FH59
Thr103-Arg227 (Cys156Ser)
Accession # Q6FH59
Specificity
Detects human VEGF-C in direct ELISAs and Western blots. In direct ELISAs, this antibody does not cross-react with recombinant human (rh) PDGF‑AA, rhPDGF‑BB, rhPlGF, rhVEGF165, rhVEGF206, rhVEGF-B186, or rhVEGF-D.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for VEGF-C Antibody (193208) [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VEGF-C
Long Name
Vascular Endothelial Growth Factor C
Alternate Names
VEGFC
Gene Symbol
VEGFC
Additional VEGF-C Products
Product Documents for VEGF-C Antibody (193208) [FITC]
Product Specific Notices for VEGF-C Antibody (193208) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...